Special Issue "Nano- and Micro-Technologies for the Treatment of Type-1 Diabetes"
Deadline for manuscript submissions: 10 February 2023 | Viewed by 1525
Interests: cellular and molecular biotechnologies; nano- and micro-drug delivery systems (DDS); diabetes; control released of insulin
Interests: biomedical polymers and biomaterials; biomedical engineering and biological modelling; cell delivery and cell therapy; gene delivery and gene therapy
Diabetes is a metabolic disease characterized by elevated blood glucose levels (BGLs) and the inability to maintain BGL homeostasis. Specifically, type 1 diabetic patients cannot produce insulin as a result of autoimmune destruction of beta cells within the pancreas. Current treatment strategies consist of multiple, daily injections of insulin or transplantation of either the whole pancreas or isolated pancreatic islets. While there are different forms of insulin with tunable pharmacokinetics (fast, intermediate, and long acting), improper dosing continues to be a major limitation often leading to complications resulting from either hyper- or hypoglycemia. On the other hand, islet transplantation is a promising strategy but requires multiple donors per patient. and post-transplantation islet survival is impaired by inflammation and suboptimal revascularization. Nano- and micro-technologies in diabetes research have facilitated the development of novel glucose measurement and insulin delivery modalities which can dramatically improve the quality of life for diabetics and contribute to realize an artificial pancreas-like system. The scope of this Special Issue is to gather recent progress in the field of diabetes research at its interface with nano- and micro-technologies.
Dr. Rosita Primavera
Prof. Dr. Longhai Wang
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- glucose sensor